Cynosure, Inc.

Shareholder Corporation Litigation

Rigrodsky & Long, P.A. Announces Investigation Of Cynosure, Inc. (NASDAQ GS: CYNO) Buyout

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Cynosure, Inc. (“Cynosure” or the “Company”) (NASDAQ GS: CYNO) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Hologic, Inc. (“Hologic”) (NASDAQ GS: HOLX), in a transaction valued at approximately $1.65 billion.

Under the terms of the agreement, shareholders of Cynosure will receive $66.00 in cash for each share of Cynosure common stock.

The investigation concerns whether Cynosure’s board of directors failed to adequately shop the Company and obtain the best possible value for Cynosure shareholders before entering into an agreement with Hologic.

If you own the common stock of Cynosure and purchased your shares before February 14, 2017, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail to

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.